C-reactive protein (CRP) levels are an independent prognostic marker in melanoma, according to a study published online March 16 in the Journal of Clinical Oncology.
MRV Research
Effective Triple Therapy for Metastatic Melanoma Based on Radiation and Dual Immunotherapy
A new study was recently published in the journal Nature showing an effective combination therapy for metastatic melanoma treatment along with the resistance mechanism underlying combined radiation therapy and ipilimumab in both patients and mice. The study is entitled “Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer.”
Researchers Discover Genetic Alterations in Children and Adolescents with Melanoma
Researchers from the St. Jude Children’s Research Hospital — Washington University Pediatric Cancer Genome Project were able to identify the genetic foundations of three different pediatric melanoma subtypes. These new discoveries could potentially lead to a more accurate diagnosis and personalized treatments. The study with the findings is published in the Journal of Investigational Dermatology
Higher C-Reactive Protein Predicts Worse Survival in Melanoma
Higher c-reactive protein (CRP) is associated with worse survival in patients with melanoma, according to a recent study published online ahead of print in the Journal of Clinical Oncology.